Lofexidine hydrochloride

Known as: 2-(1-(2,6-Dichlorophenoxy)Ethyl)-2-Imidazoline Monohydrochloride, 1H-Imidazole, 2-(1-(2,6-Dichlorophenoxy)Ethyl)-4,5-Dihydro-, Monohydrochloride, Lofexidine mono-hydrochloride 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2017
01219902017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Lofexidine is an alpha-2-adrenergic receptor agonist approved in the United Kingdom (UK) for the treatment of opioid… (More)
  • figure 2
  • figure 3
  • figure 4
  • table 1
  • table 2
Is this relevant?
2009
2009
OBJECTIVES The objective of this study was to investigate lofexidine urine and plasma pharmacokinetics using three different… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
2009
2009
The objective of this study was to characterize the clinical pharmacokinetic profile of lofexidine after oral delivery. A single… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2005
2005
OBJECTIVE To make technical standard of acupuncture manipulation for acupuncture treatment of heroin withdrawal syndrome… (More)
Is this relevant?
2004
2004
OBJECTIVE To observe the therapeutic effect of Modified Banxia Houpu Decoction (MBHD) in treating heroin abusers with protracted… (More)
Is this relevant?
2001
2001
BACKGROUND We hypothesised that the orally-active alpha(2)-adrenoceptor agonist lofexidine hydrochloride would ameliorate chronic… (More)
Is this relevant?
Review
1990
Review
1990
This article discusses current pharmacologic methods in the treatment of heroin dependence and withdrawal. Methadone… (More)
Is this relevant?